MMCM
SNY icon

Murphy & Mullick Capital Management’s Sanofi SNY Stock Holding History

Murphy & Mullick Capital Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100
Closed -$4.56K – 683
2025
Q2 		$4.56K Buy
+100
New +$5.11K ﹤0.01% 527

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Murphy & Mullick Capital Management's SNY Position: Q3 2025 in Review

Murphy & Mullick Capital Management sold out of Sanofi (SNY) in Q3 2025, closing a stake of 100 shares — an estimated $4.56K sold.

Murphy & Mullick Capital Management first reported a position in SNY in Q2 2025 and held it in 1 quarter. The position peaked at $4.56K in Q2 2025. 712 funds tracked by Wall St. Rank hold SNY as of Q3 2025.

  • Murphy & Mullick Capital Management reported no remaining Sanofi position as of Q3 2025 after selling out during the quarter.
  • Murphy & Mullick Capital Management sold 100 Sanofi shares in Q3 2025, an estimated $4.56K.
  • Murphy & Mullick Capital Management first reported a position in Sanofi in Q2 2025 and held it in 1 quarter.
  • Murphy & Mullick Capital Management's Sanofi position peaked at $4.56K in Q2 2025.
  • 712 funds tracked by Wall St. Rank held Sanofi as of Q3 2025.

Based on Murphy & Mullick Capital Management's 13F filing for Q3 2025, filed 7 Nov 2025.